This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM, Rodriguez-Tudela JL. Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids. 2008 Mar;73(3):339–347. https://doi.org/10.1016/j.steroids.2007.11.005Alcazar-FuoliLMelladoEGarcia-EffronGLopezJFGrimaltJOCuenca-EstrellaJMRodriguez-TudelaJL.Ergosterol biosynthesis pathway in Aspergillus fumigatus.Steroids.2008Mar;73(3):339–347. https://doi.org/10.1016/j.steroids.2007.11.005Open DOISearch in Google Scholar
Albarrag AM, Anderson MJ, Howard SJ, Robson GD, Warn PA, Sanglard D, Denning DW. Interrogation of related clinical panazole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother. 2011 Nov; 55(11):5113–5121. https://doi.org/10.1128/AAC.00517-11AlbarragAMAndersonMJHowardSJRobsonGDWarnPASanglardDDenningDW.Interrogation of related clinical panazole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter.Antimicrob Agents Chemother.2011Nov;55(11):5113–5121. https://doi.org/10.1128/AAC.00517-11Open DOISearch in Google Scholar
Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997 Sep; 25(17):3389–3402. https://doi.org/10.1093/nar/25.17.3389AltschulSFMaddenTLSchäfferAAZhangJZhangZMillerWLipmanDJ.Gapped BLAST and PSI-BLAST: A new generation of protein database search programs.Nucleic Acids Res.1997Sep;25(17):3389–3402. https://doi.org/10.1093/nar/25.17.3389Open DOISearch in Google Scholar
Arikan-Akdagli S, Ghannoum M, Meis JF. Antifungal resistance: Specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus. J Fungi. 2018 Dec; 4(4):129. https://doi.org/10.3390/jof4040129Arikan-AkdagliSGhannoumMMeisJF.Antifungal resistance: Specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus.J Fungi.2018Dec;4(4):129. https://doi.org/10.3390/jof4040129Open DOISearch in Google Scholar
Baranyi N, Kocsubé S, Jakšić Despot D, Šegvić Klarić M, Szekeres A, Bencsik O, Kecskeméti A, Manikandan P, et al. Combined genotyping strategy reveals structural differences between Aspergillus flavus lineages from different habitats impacting human health. J Basic Microbiol. 2017 Nov;57(11):899–909. https://doi.org/10.1002/jobm.201700243BaranyiNKocsubéSJakšić DespotDŠegvić KlarićMSzekeresABencsikOKecskemétiAManikandanP.Combined genotyping strategy reveals structural differences between Aspergillus flavus lineages from different habitats impacting human health.J Basic Microbiol.2017Nov;57(11):899–909. https://doi.org/10.1002/jobm.201700243Open DOISearch in Google Scholar
Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Gallo Cassarino T, Bertoni M, Bordoli L, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014 Jul;42(W1):W252–W258. https://doi.org/10.1093/nar/gku340BiasiniMBienertSWaterhouseAArnoldKStuderGSchmidtTKieferFGallo CassarinoTBertoniMBordoliL.SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.Nucleic Acids Res.2014Jul;42(W1):W252–W258. https://doi.org/10.1093/nar/gku340Open DOISearch in Google Scholar
Buil JB, Zoll J, Verweij PE, Melchers WJG. Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples. Front Microbiol. 2018 Mar;9:515. https://doi.org/10.3389/fmicb.2018.00515BuilJBZollJVerweijPEMelchersWJG.Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples.Front Microbiol.2018Mar;9:515. https://doi.org/10.3389/fmicb.2018.00515Open DOISearch in Google Scholar
Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: A case study and review of the literature. Antimicrob Agents Chemother. 2012 Jan;56(1):10–16. https://doi.org/10.1128/AAC.05088-11CampsSMvan der LindenJWLiYKuijperEJvan DisselJTVerweijPEMelchersWJ.Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: A case study and review of the literature.Antimicrob Agents Chemother.2012Jan;56(1):10–16. https://doi.org/10.1128/AAC.05088-11Open DOISearch in Google Scholar
Celia-Sanchez BN, Mangum B, Brewer M, Momany M. Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi. G3 Genes Genomes Genet. 2022 Nov;12(11):jkac249. https://doi.org/10.1093/g3journal/jkac249Celia-SanchezBNMangumBBrewerMMomanyM.Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi.G3 Genes Genomes Genet.2022Nov;12(11):jkac249. https://doi.org/10.1093/g3journal/jkac249Open DOISearch in Google Scholar
Chen J, Li H, Li R, Bu D, Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 2005 Jan;55(1):31–37. https://doi.org/10.1093/jac/dkh507ChenJLiHLiRBuDWanZ.Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.J Antimicrob Chemother.2005Jan;55(1):31–37. https://doi.org/10.1093/jac/dkh507Open DOISearch in Google Scholar
Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017 Aug;216(suppl_3):S436–S444. https://doi.org/10.1093/infdis/jix210ChowdharyASharmaCMeisJF.Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment.J Infect Dis.2017Aug;216(suppl_3):S436–S444. https://doi.org/10.1093/infdis/jix210Open DOISearch in Google Scholar
Da Silva Ferreira ME, Colombo AL, Paulsen I, Ren Q, Wortman J, Huang J, Goldman MHS, Goldman GH. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med Mycol. 2005 Jan;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114Da Silva FerreiraMEColomboALPaulsenIRenQWortmanJHuangJGoldmanMHSGoldmanGH.The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.Med Mycol.2005Jan;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114Open DOISearch in Google Scholar
de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, Padín-González C, Burger E, Badali H, Richard-Yegres N, van den Ende AH. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol. 2007;58:219–34. https://doi.org/10.3114/sim.2007.58.08de HoogGSNishikakuASFernandez-ZeppenfeldtGPadín-GonzálezCBurgerEBadaliHRichard-YegresNvan den EndeAH.Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species.Stud Mycol.2007;58:219–34. https://doi.org/10.3114/sim.2007.58.08Open DOISearch in Google Scholar
Denning DW, Perlin DS. Azole resistance in Aspergillus: A growing public health menace. Future Microbiol. 2011 Nov;6(11):1229–32. https://doi.org/10.2217/fmb.11.118DenningDWPerlinDS.Azole resistance in Aspergillus: A growing public health menace.Future Microbiol.2011Nov;6(11):1229–32. https://doi.org/10.2217/fmb.11.118Open DOISearch in Google Scholar
Espinel-Ingroff A, Turnidge J. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds. Rev Iberoam Micol. 2016 Apr-Jun;33(2):63–75. https://doi.org/10.1016/j.riam.2016.04.001Espinel-IngroffATurnidgeJ.The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.Rev Iberoam Micol.2016Apr-Jun;33(2):63–75. https://doi.org/10.1016/j.riam.2016.04.001Open DOISearch in Google Scholar
Fattahi A, Zaini F, Kordbacheh P, Rezaie S, Safara M, Fateh R, Farahyar S, Kanani A, Heidari M. Evaluation of mRNA expression levels of cyp51A and mdr1, candidate genes for voriconazole resistance in Aspergillus flavus. Jundishapur J Microbiol. 2015; 8(12): e26990. https://doi.org/10.5812/jjm.26990FattahiAZainiFKordbachehPRezaieSSafaraMFatehRFarahyarSKananiAHeidariM.Evaluation of mRNA expression levels of cyp51A and mdr1, candidate genes for voriconazole resistance in Aspergillus flavus.Jundishapur J Microbiol.2015;8(12): e26990. https://doi.org/10.5812/jjm.26990Open DOISearch in Google Scholar
Ferreira ME, Colombo AL, Paulsen I, Ren Q, Wortman J, Huang J, Goldman MH, Goldman GH. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med Mycol. 2005 May;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114FerreiraMEColomboALPaulsenIRenQWortmanJHuangJGoldmanMHGoldmanGH.The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.Med Mycol.2005May;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114Open DOISearch in Google Scholar
Fuhren J, Voskuil WS, Boel CH, Haas PJ, Hagen F, Meis JF, Kusters JG. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. J Antimicrob Chemother. 2015 Oct;70(10):2894–2898. https://doi.org/10.1093/jac/dkv177FuhrenJVoskuilWSBoelCHHaasPJHagenFMeisJFKustersJG.High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.J Antimicrob Chemother.2015Oct;70(10):2894–2898. https://doi.org/10.1093/jac/dkv177Open DOISearch in Google Scholar
Furukawa T, van Rhijn N, Fraczek M, Gsaller F, Davies E, Carr P, Gago S, Fortune-Grant R, Rahman S, Gilsenan JM, et al. The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus. Nat Commun. 2020 Jan;11(1):427. https://doi.org/10.1038/s41467-019-14191-1FurukawaTvan RhijnNFraczekMGsallerFDaviesECarrPGagoSFortune-GrantRRahmanSGilsenanJM.The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus.Nat Commun.2020Jan;11(1):427. https://doi.org/10.1038/s41467-019-14191-1Open DOISearch in Google Scholar
Garcia-Effron G, Mellado E, Gomez-Lopez A, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus. Antimicrob Agents Chemother. 2005 May;49(5):2119–2121. https://doi.org/10.1128/AAC.49.5.2119-2121.2005Garcia-EffronGMelladoEGomez-LopezAAlcazar-FuoliLCuenca-EstrellaMRodriguez-TudelaJL.Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.Antimicrob Agents Chemother.2005May;49(5):2119–2121. https://doi.org/10.1128/AAC.49.5.2119-2121.2005Open DOISearch in Google Scholar
Gonzalez-Jimenez I, Lucio J, Amich J, Cuesta I, Sanchez Arroyo R, Alcazar-Fuoli L, Mellado E. A Cyp51B mutation contributes to azole resistance in Aspergillus fumigatus. J Fungi. 2020 Nov;6(4):315. https://doi.org/10.3390/jof6040315Gonzalez-JimenezILucioJAmichJCuestaISanchez ArroyoRAlcazar-FuoliLMelladoE.A Cyp51B mutation contributes to azole resistance in Aspergillus fumigatus.J Fungi.2020Nov;6(4):315. https://doi.org/10.3390/jof6040315Open DOISearch in Google Scholar
Hadrich I, Makni F, Neji S, Abbes S, Cheikhrouhou F, Trabelsi H, Sellami H, Ayadi A. Invasive aspergillosis: Resistance to antifungal drugs. Mycopathologia. 2012a Aug;174(2):131–141. https://doi.org/10.1007/s11046-012-9526-yHadrichIMakniFNejiSAbbesSCheikhrouhouFTrabelsiHSellamiHAyadiA.Invasive aspergillosis: Resistance to antifungal drugs.Mycopathologia.2012aAug;174(2):131–141. https://doi.org/10.1007/s11046-012-9526-yOpen DOISearch in Google Scholar
Hadrich I, Makni F, Neji S, Cheikhrouhou F, Bellaaj H, Elloumi M, Ayadi A, Ranque S. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012b Nov; 50(8):829–834. https://doi.org/10.3109/13693786.2012.684154HadrichIMakniFNejiSCheikhrouhouFBellaajHElloumiMAyadiARanqueS.Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection.Med Mycol.2012bNov;50(8):829–834. https://doi.org/10.3109/13693786.2012.684154Open DOISearch in Google Scholar
Hadrich I, Makni F, Sellami H, Cheikhrouhou F, Sellami A, Bouaziz H, Hdiji S, Elloumi M, Ayadi A. Invasive aspergillosis: Epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses. 2010 Sep;53(5):443–447. https://doi.org/10.1111/j.1439-0507.2009.01710.xHadrichIMakniFSellamiHCheikhrouhouFSellamiABouazizHHdijiSElloumiMAyadiA.Invasive aspergillosis: Epidemiology and environmental study in haematology patients (Sfax, Tunisia).Mycoses.2010Sep;53(5):443–447. https://doi.org/10.1111/j.1439-0507.2009.01710.xOpen DOISearch in Google Scholar
Hagiwara D, Watanabe A, Kamei K, Goldman GH. Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus Fungi. Front Microbiol. 2016 Sep;7:1382. https://doi.org/10.3389/fmicb.2016.01382HagiwaraDWatanabeAKameiKGoldmanGH.Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus Fungi.Front Microbiol.2016Sep;7:1382. https://doi.org/10.3389/fmicb.2016.01382Open DOISearch in Google Scholar
Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ, Schotzinger RJ, York JD, Guengerich FP, Lepesheva GI. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem. 2017a Apr;292(16): 6728–6743. https://doi.org/10.1074/jbc.M117.778308HargroveTYFriggeriLWawrzakZQiAHoekstraWJSchotzingerRJYorkJDGuengerichFPLepeshevaGI.Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis.J Biol Chem.2017aApr;292(16):6728–6743. https://doi.org/10.1074/jbc.M117.778308Open DOISearch in Google Scholar
Hargrove TY, Garvey EP, Hoekstra WJ, Yates CM, Wawrzak Z, Rachakonda G, Villalta F, Lepesheva GI. Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14α-demethylase provides insights into its broad-spectrum antifungal activity. Antimicrob Agents Chemother. 2017b Jun;61(7):e00570-17. https://doi.org/10.1128/AAC.00570-17HargroveTYGarveyEPHoekstraWJYatesCMWawrzakZRachakondaGVillaltaFLepeshevaGI.Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14α-demethylase provides insights into its broad-spectrum antifungal activity.Antimicrob Agents Chemother.2017bJun;61(7):e00570-17. https://doi.org/10.1128/AAC.00570-17Open DOISearch in Google Scholar
Hawkins NJ, Cools HJ, Sierotzki H, Shaw MW, Knogge W, Kelly SL, Kelly DE, Fraaije BA. Paralog re-emergence: A novel, historically contingent mechanism in the evolution of antimicrobial resistance. Mol Biol Evol. 2014 Jul;31(7):1793–1802. https://doi.org/10.1093/molbev/msu134HawkinsNJCoolsHJSierotzkiHShawMWKnoggeWKellySLKellyDEFraaijeBA.Paralog re-emergence: A novel, historically contingent mechanism in the evolution of antimicrobial resistance.Mol Biol Evol.2014Jul;31(7):1793–1802. https://doi.org/10.1093/molbev/msu134Open DOISearch in Google Scholar
Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW.Aspergillus flavus: Human pathogen, allergen and mycotoxin producer. Microbiology. 2007 Jun;153(6):1677–1692. https://doi.org/10.1099/mic.0.2007/007641-0HedayatiMTPasqualottoACWarnPABowyerPDenningDW.Aspergillus flavus: Human pathogen, allergen and mycotoxin producer.Microbiology.2007Jun;153(6):1677–1692. https://doi.org/10.1099/mic.0.2007/007641-0Open DOISearch in Google Scholar
Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: Epidemiology and detection. Med Mycol. 2011 Apr;49(Suppl_1):S90–S95. https://doi.org/10.3109/13693786.2010.508469HowardSJArendrupMC.Acquired antifungal drug resistance in Aspergillus fumigatus: Epidemiology and detection.Med Mycol.2011Apr;49(Suppl_1):S90–S95. https://doi.org/10.3109/13693786.2010.508469Open DOISearch in Google Scholar
Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009 Jul;15(7):1068–1076. https://doi.org/10.3201/eid1507.090043HowardSJCerarDAndersonMJAlbarragAFisherMCPasqualottoACLaverdiereMArendrupMCPerlinDSDenningDW.Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.Emerg Infect Dis.2009Jul;15(7):1068–1076. https://doi.org/10.3201/eid1507.090043Open DOISearch in Google Scholar
Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect. 2010 Jun;16(6):683–688. https://doi.org/10.1111/j.1469-0691.2009.02911.xHowardSJPasqualottoACDenningDW.Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.Clin Microbiol Infect.2010Jun;16(6):683–688. https://doi.org/10.1111/j.1469-0691.2009.02911.xOpen DOISearch in Google Scholar
Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007 May;23(10): 1289–1291. https://doi.org/10.1093/bioinformatics/btm091KoressaarTRemmM.Enhancements and modifications of primer design program Primer3.Bioinformatics.2007May;23(10):1289–1291. https://doi.org/10.1093/bioinformatics/btm091Open DOISearch in Google Scholar
Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents. 2008 Dec; 32(6): 519–524. https://doi.org/10.1016/j.ijantimicag.2008.06.018Krishnan-NatesanSChandrasekarPHAlangadenGJManavathuEK.Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.Int J Antimicrob Agents.2008Dec;32(6):519–524. https://doi.org/10.1016/j.ijantimicag.2008.06.018Open DOISearch in Google Scholar
Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2012 Nov;74(3):272–277. https://doi.org/10.1016/j.diagmicrobio.2012.06.030Krishnan NatesanSWuWCutrightJLChandrasekarPH.In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.Diagn Microbiol Infect Dis.2012Nov;74(3):272–277. https://doi.org/10.1016/j.diagmicrobio.2012.06.030Open DOISearch in Google Scholar
Lescar J, Meyer I, Akshita K, Srinivasaraghavan K, Verma C, Palous M, Mazier D, Datry A, Fekkar A.Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. J Antimicrob Chemother. 2014 Dec;69(12):3244–3247. https://doi.org/10.1093/jac/dku316LescarJMeyerIAkshitaKSrinivasaraghavanKVermaCPalousMMazierDDatryAFekkarA.Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.J Antimicrob Chemother.2014Dec;69(12):3244–3247. https://doi.org/10.1093/jac/dku316Open DOISearch in Google Scholar
Liu W, Sun Y, Chen W, Liu W, Wan Z, Bu D, Li R. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis. Antimicrob Agents Chemother. 2012 May;56(5):2598–603. https://doi.org/10.1128/AAC.05477-11LiuWSunYChenWLiuWWanZBuDLiR.The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.Antimicrob Agents Chemother.2012May;56(5):2598–603. https://doi.org/10.1128/AAC.05477-11Open DOISearch in Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods. 2001 Dec;25(4):402–408. https://doi.org/10.1006/meth.2001.1262LivakKJSchmittgenTD.Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method.Methods.2001Dec;25(4):402–408. https://doi.org/10.1006/meth.2001.1262Open DOISearch in Google Scholar
Lucio J, Gonzalez-Jimenez I, Rivero-Menendez O, Alastruey-Izquierdo A, Pelaez T, Alcazar-Fuoli L, Mellado E. Point mutations in the 14-α sterol demethylase Cyp51A or Cyp51C could contribute to azole resistance in Aspergillus flavus. Genes. 2020 Oct; 11(10):1217. https://doi.org/10.3390/genes11101217LucioJGonzalez-JimenezIRivero-MenendezOAlastruey-IzquierdoAPelaezTAlcazar-FuoliLMelladoE.Point mutations in the 14-α sterol demethylase Cyp51A or Cyp51C could contribute to azole resistance in Aspergillus flavus.Genes.2020Oct;11(10):1217. https://doi.org/10.3390/genes11101217Open DOISearch in Google Scholar
Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, DiDomenico B, Hare RS, Walker SS, McNicholas PM. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother. 2003 Feb;47(2):577–81. https://doi.org/10.1128/AAC.47.2.577-581.2003MannPAParmegianiRMWeiSQMendrickCALiXLoebenbergDDiDomenicoBHareRSWalkerSSMcNicholasPM.Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.Antimicrob Agents Chemother.2003Feb;47(2):577–81. https://doi.org/10.1128/AAC.47.2.577-581.2003Open DOISearch in Google Scholar
Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ. FireDock: A web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008 Jul;36(suppl_2): W229–W232. https://doi.org/10.1093/nar/gkn186MashiachESchneidman-DuhovnyDAndrusierNNussinovRWolfsonHJ.FireDock: A web server for fast interaction refinement in molecular docking.Nucleic Acids Res.2008Jul;36(suppl_2): W229–W232. https://doi.org/10.1093/nar/gkn186Open DOISearch in Google Scholar
Meena DS, Kumar D, Bohra GK, Kumar G. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases. Infect Dis Now. 2021 Nov;51(8): 654–660. https://doi.org/10.1016/j.idnow.2021.04.002MeenaDSKumarDBohraGKKumarG.Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases.Infect Dis Now.2021Nov;51(8):654–660. https://doi.org/10.1016/j.idnow.2021.04.002Open DOISearch in Google Scholar
Mellado E, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility. Antimicrob Agents Chemother. 2011 Dec;55(12):5459–5468. https://doi.org/10.1128/AAC.05178-11MelladoEAlcazar-FuoliLCuenca-EstrellaMRodriguez-TudelaJL.Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility.Antimicrob Agents Chemother.2011Dec;55(12):5459–5468. https://doi.org/10.1128/AAC.05178-11Open DOISearch in Google Scholar
Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol. 2001 Jul;39(7):2431–2438. https://doi.org/10.1128/JCM.39.7.2431-2438.2001MelladoEDiaz-GuerraTMCuenca-EstrellaMRodriguez-TudelaJL.Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species.J Clin Microbiol.2001Jul;39(7):2431–2438. https://doi.org/10.1128/JCM.39.7.2431-2438.2001Open DOISearch in Google Scholar
Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother. 2004 Jul;48(7):2747–2750. https://doi.org/10.1128/AAC.48.7.2747-2750.2004MelladoEGarcia-EffronGAlcazar-FuoliLCuenca-EstrellaMRodriguez-TudelaJL.Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs.Antimicrob Agents Chemother.2004Jul;48(7):2747–2750. https://doi.org/10.1128/AAC.48.7.2747-2750.2004Open DOISearch in Google Scholar
Monk BC, Tomasiak TM, Keniya MV, Huschmann FU, Tyndall JD, O’Connell JD 3rd, Cannon RD, McDonald JG, Rodriguez A, Finer-Moore JS, et al. Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci USA. 2014 Mar;111(10):3865–3870. https://doi.org/10.1073/pnas.1324245111MonkBCTomasiakTMKeniyaMVHuschmannFUTyndallJDO’ConnellJD3rdCannonRDMcDonaldJGRodriguezAFiner-MooreJS.Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer.Proc Natl Acad Sci USA.2014Mar;111(10):3865–3870. https://doi.org/10.1073/pnas.1324245111Open DOISearch in Google Scholar
Nascimento AM, Goldman GH, Park S, Marras SA, Delmas G, Oza U, Lolans K, Dudley MN, Mann PA, Perlin DS. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother. 2003 May;47(5):1719–1726. https://doi.org/10.1128/AAC.47.5.1719-1726.2003NascimentoAMGoldmanGHParkSMarrasSADelmasGOzaULolansKDudleyMNMannPAPerlinDS.Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole.Antimicrob Agents Chemother.2003May;47(5):1719–1726. https://doi.org/10.1128/AAC.47.5.1719-1726.2003Open DOISearch in Google Scholar
Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, Arroyo J, Berriman M, Abe K, Archer DB, Bermejo C, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature. 2005 Dec;438(7071):1151–6. https://doi.org/10.1038/nature04332NiermanWCPainAAndersonMJWortmanJRKimHSArroyoJBerrimanMAbeKArcherDBBermejoC.Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus.Nature.2005Dec;438(7071):1151–6. https://doi.org/10.1038/nature04332Open DOISearch in Google Scholar
Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug;63(4):e1–e60. https://doi.org/10.1093/cid/ciw326PattersonTFThompsonGR3rdDenningDWFishmanJAHadleySHerbrechtRKontoyiannisDPMarrKAMorrisonVANguyenMH.Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America.Clin Infect Dis.2016Aug;63(4):e1–e60. https://doi.org/10.1093/cid/ciw326Open DOISearch in Google Scholar
Paul RA, Rudramurthy SM, Meis JF, Mouton JW, Chakrabarti A. A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus. Antimicrob Agents Chemother. 2015 Oct; 59(10):6615–6619. https://doi.org/10.1128/AAC.00637-15PaulRARudramurthySMMeisJFMoutonJWChakrabartiA.A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus.Antimicrob Agents Chemother.2015Oct;59(10):6615–6619. https://doi.org/10.1128/AAC.00637-15Open DOISearch in Google Scholar
Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, Brackin AP, van Rhijn N, Chown H, Tsitsopoulou A, et al. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol. 2022 May;7(5):663–674. https://doi.org/10.1038/s41564-022-01091-2RhodesJAbdolrasouliADunneKSewellTRZhangYBallardEBrackinAPvan RhijnNChownHTsitsopoulouA.Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment.Nat Microbiol.2022May;7(5):663–674. https://doi.org/10.1038/s41564-022-01091-2Open DOISearch in Google Scholar
Sagatova AA, Keniya MV, Wilson RK, Monk BC, Tyndall JD. Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14α-demethylase. Antimicrob Agents Chemother. 2015 Aug;59(8):4982–9. https://doi.org/10.1128/AAC.00925-15SagatovaAAKeniyaMVWilsonRKMonkBCTyndallJD.Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14α-demethylase.Antimicrob Agents Chemother.2015Aug;59(8):4982–9. https://doi.org/10.1128/AAC.00925-15Open DOISearch in Google Scholar
Sharma C, Kumar R, Kumar N, Masih A, Gupta D, Chowdhary A. Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India. Antimicrob Agents Chemother. 2018 Feb;62(3):e01928–17. https://doi.org/10.1128/AAC.01928-17SharmaCKumarRKumarNMasihAGuptaDChowdharyA.Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India.Antimicrob Agents Chemother.2018Feb;62(3):e01928–17. https://doi.org/10.1128/AAC.01928-17Open DOISearch in Google Scholar
Shelton JMG, Rhodes J, Uzzell CB, Hemmings S, Brackin AP, Sewell TR, Alghamdi A, Dyer PS, Fraser M, Borman AM, et al. Citizen science reveals landscape-scale exposures to multiazoleresistant Aspergillus fumigatus bioaerosols. Sci Adv. 2023 Jul;9(29): eadh8839. https://doi.org/10.1126/sciadv.adh8839SheltonJMGRhodesJUzzellCBHemmingsSBrackinAPSewellTRAlghamdiADyerPSFraserMBormanAM.Citizen science reveals landscape-scale exposures to multiazoleresistant Aspergillus fumigatus bioaerosols.Sci Adv.2023Jul;9(29): eadh8839. https://doi.org/10.1126/sciadv.adh8839Open DOISearch in Google Scholar
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011 Oct;7:539. https://doi.org/10.1038/msb.2011.75SieversFWilmADineenDGibsonTJKarplusKLiWLopezRMcWilliamHRemmertMSödingJ.Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.Mol Syst Biol.2011Oct;7:539. https://doi.org/10.1038/msb.2011.75Open DOISearch in Google Scholar
Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008 Nov;5(11):e219. https://doi.org/10.1371/journal.pmed.0050219SneldersEvan der LeeHAKuijpersJRijsAJVargaJSamsonRAMelladoEDondersARMelchersWJVerweijPE.Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.PLoS Med.2008Nov;5(11):e219. https://doi.org/10.1371/journal.pmed.0050219Open DOISearch in Google Scholar
Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques. 2000 Jun;28(6):1102–1104. https://doi.org/10.2144/00286ir01StothardP.The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences.Biotechniques.2000Jun;28(6):1102–1104. https://doi.org/10.2144/00286ir01Open DOISearch in Google Scholar
Thenmozhi M, Kannabiran K. Interaction of Streptomyces sp. VITSTK7 compounds with selected antifungal drug target enzymes by in silico molecular docking studies. Interdiscip Sci. 2013 Jun;5(2): 145–149. https://doi.org/10.1007/s12539-013-0163-zThenmozhiMKannabiranK.Interaction of Streptomyces sp. VITSTK7 compounds with selected antifungal drug target enzymes by in silico molecular docking studies.Interdiscip Sci.2013Jun;5(2):145–149. https://doi.org/10.1007/s12539-013-0163-zOpen DOISearch in Google Scholar
Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. Primer3 – new capabilities and interfaces. Nucleic Acids Res. 2012 Aug;40(15):e115. https://doi.org/10.1093/nar/gks596UntergasserACutcutacheIKoressaarTYeJFairclothBCRemmMRozenSG.Primer3 – new capabilities and interfaces.Nucleic Acids Res.2012Aug;40(15):e115. https://doi.org/10.1093/nar/gks596Open DOISearch in Google Scholar
Van Rhijn N, Bromley M, Richardson M, Bowyer P. CYP51 paralogue structure is associated with intrinsic azole resistance in fungi. mBio. 2021 Oct 26;12(5):e0194521. https://doi.org/10.1128/mBio.01945-21Van RhijnNBromleyMRichardsonMBowyerP.CYP51 paralogue structure is associated with intrinsic azole resistance in fungi.mBio.2021Oct26;12(5):e0194521. https://doi.org/10.1128/mBio.01945-21Open DOISearch in Google Scholar
VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques. 2008 Apr;44(5):619–626. https://doi.org/10.2144/000112776VanGuilderHDVranaKEFreemanWM.Twenty-five years of quantitative PCR for gene expression analysis.Biotechniques.2008Apr;44(5):619–626. https://doi.org/10.2144/000112776Open DOISearch in Google Scholar
Vermeulen E, Lagrou K, Verweij PE. Azole resistance in Aspergillus fumigatus: A growing public health concern. Curr Opin Infect Dis. 2013 Dec;26(6):493–500. https://doi.org/10.1097/QCO.0000000000000005VermeulenELagrouKVerweijPE.Azole resistance in Aspergillus fumigatus: A growing public health concern.Curr Opin Infect Dis.2013Dec;26(6):493–500. https://doi.org/10.1097/QCO.0000000000000005Open DOISearch in Google Scholar
Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of moldactive antifungal azoles? Clin Infect Dis. 2016 Feb;62(3):362–368. https://doi.org/10.1093/cid/civ885VerweijPEChowdharyAMelchersWJMeisJF.Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of moldactive antifungal azoles?Clin Infect Dis.2016Feb;62(3):362–368. https://doi.org/10.1093/cid/civ885Open DOISearch in Google Scholar